Article

p53 is Functionally Inhibited in Clear Cell Renal Cell Carcinoma (Ccrcc): A Mechanistic and Correlative Investigation into Genetic and Molecular Characteristics.

2021-05-20

Abstract excerpt

<title>Abstract</title> <p>Purpose Although p53 is rarely mutated in ccRCC, its overexpression has been linked to poor prognosis. The current study sought to elucidate the unique role of p53 in ccRCC with genomic, proteomic, and functional analyses. Materials and Methods Data from the Cancer Genome Atlas (TCGA) were evaluated for genomic and proteomic characteristics of p53; a tissue micro array (TMA) study was...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6085445d-69e3-5c47-a8ff-1cb45e44abeb
DOI: 10.21203/rs.3.rs-325922/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

p53 is Functionally Inhibited in Clear Cell Renal Cell Carcinoma (Ccrcc): A Mechanistic and Correlative Investigation into Genetic and Molecular Characteristics.DOI 10.21203/rs.3.rs-325922/v1Read

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.Semantic proximity Read

The Underestimated Role of the p53 Pathway in Renal CancerSemantic proximity Read

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.Semantic proximity Read

Epigenetic silencing of ASPP1 confers 5‐FU resistance in clear cell renal cell carcinoma by preventing p53 activationSemantic proximity Read

p53 Regulation and Function in Renal Cell CarcinomaSemantic proximity Read

Developing novel therapeutic strategies for targeting the p53 pathway in renal cell carcinomaSemantic proximity Read

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaSemantic proximity Read

Functional and gene expression analysis of the p53 signaling pathway in clear cell sarcoma of the kidney and congenital mesoblastic nephroma.Semantic proximity Read

Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.Semantic proximity Read

p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Semantic proximity Read

Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.Semantic proximity Read

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.Semantic proximity Read